Risk for Most Cardiovascular Events Reduced After COVID-19 Vaccination
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 16, 2024 -- COVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis after mRNA vaccination, according to a study published online Sept. 30 in the European Heart Journal.
Yiyi Xu, Ph.D., from the University of Gothenburg in Sweden, and colleagues examined the risks for several cardiovascular and cerebrovascular events in a nationwide register-based cohort (8,070,674 Swedish adults). The postvaccination risk for myocarditis/pericarditis, dysrhythmias, heart failure, myocardial infarction, and cerebrovascular events (transient ischemic attack and stroke) was examined in several risk windows after each vaccine dose.
The researchers found reduced risks for cardiovascular events postvaccination for most of the studied outcomes, especially after dose 3 (hazard ratios ranging from 0.69 to 0.81), while the risks for myocarditis and pericarditis were increased one to two weeks after COVID-19 mRNA vaccination. Across vaccines, similar slightly increased risks were seen for extrasystoles (hazard ratios, 1.17 and 1.22 for doses 1 and 2, respectively, which were stronger in the elderly and males), but not for arrhythmias, and for transient ischemic attack (hazard ratio, 1.13, mainly in elderly), but not for stroke.
"We found decreased risks of several serious cardiovascular outcomes after COVID-19 vaccination, likely related to the protection of vaccination against severe COVID-19," the authors write. "Overall, our results clearly underscore the protective benefits of complete vaccination, especially for elderlies."
Several authors disclosed ties to pharmaceutical companies, including AstraZeneca and Pfizer.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Further Support and Information on COVID-19
Read this next
35 Percent of Eligible Children Receive RSV Prophylaxis With Nirsevimab
TUESDAY, July 22, 2025 -- Despite near universal availability of nirsevimab, only 35 percent of eligible children receive nirsevimab for respiratory syncytial virus (RSV)...
2020 to 2024 Saw Drop in Flu Vaccine Uptake Among U.S. Adults
FRIDAY, July 18, 2025 -- There was an overall decrease in influenza vaccine uptake among U.S. adults from 2020 to 2024, according to a study published online July 16 in PLOS...
Increased Risk for CVD Seen for Women With Premenstrual Disorders
THURSDAY, July 17, 2025 -- Women with premenstrual disorders (PMDs) have an increased risk for cardiovascular diseases (CVDs), according to a study published online July 11 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.